Global Prescription Gastrointestinal Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 88
Published Date: 10 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
According to our (Global Info Research) latest study, the global Prescription Gastrointestinal Drugs market size was valued at USD 29640 million in 2023 and is forecast to a readjusted size of USD 42180 million by 2030 with a CAGR of 5.2% during review period.
The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Prescription Gastrointestinal Drugs industry chain, the market status of Hospital Pharmacies (Oral, Topical), Online Pharmacies (Oral, Topical), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prescription Gastrointestinal Drugs.
Regionally, the report analyzes the Prescription Gastrointestinal Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prescription Gastrointestinal Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Prescription Gastrointestinal Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prescription Gastrointestinal Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Oral, Topical).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prescription Gastrointestinal Drugs market.
Regional Analysis: The report involves examining the Prescription Gastrointestinal Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prescription Gastrointestinal Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Prescription Gastrointestinal Drugs:
Company Analysis: Report covers individual Prescription Gastrointestinal Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prescription Gastrointestinal Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Online Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Prescription Gastrointestinal Drugs. It assesses the current state, advancements, and potential future developments in Prescription Gastrointestinal Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prescription Gastrointestinal Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Prescription Gastrointestinal Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Oral
Topical
Market segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Major players covered
AstraZeneca
Axcan Pharmaceuticals
Eisai
GlaxoSmithKline
Merck
Salix Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prescription Gastrointestinal Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prescription Gastrointestinal Drugs, with price, sales, revenue and global market share of Prescription Gastrointestinal Drugs from 2019 to 2024.
Chapter 3, the Prescription Gastrointestinal Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Gastrointestinal Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Prescription Gastrointestinal Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prescription Gastrointestinal Drugs.
Chapter 14 and 15, to describe Prescription Gastrointestinal Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Prescription Gastrointestinal Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prescription Gastrointestinal Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oral
1.3.3 Topical
1.4 Market Analysis by Application
1.4.1 Overview: Global Prescription Gastrointestinal Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Online Pharmacies
1.4.4 Retail Pharmacies
1.5 Global Prescription Gastrointestinal Drugs Market Size & Forecast
1.5.1 Global Prescription Gastrointestinal Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Prescription Gastrointestinal Drugs Sales Quantity (2019-2030)
1.5.3 Global Prescription Gastrointestinal Drugs Average Price (2019-2030)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Prescription Gastrointestinal Drugs Product and Services
2.1.4 AstraZeneca Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Axcan Pharmaceuticals
2.2.1 Axcan Pharmaceuticals Details
2.2.2 Axcan Pharmaceuticals Major Business
2.2.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
2.2.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Axcan Pharmaceuticals Recent Developments/Updates
2.3 Eisai
2.3.1 Eisai Details
2.3.2 Eisai Major Business
2.3.3 Eisai Prescription Gastrointestinal Drugs Product and Services
2.3.4 Eisai Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Eisai Recent Developments/Updates
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Product and Services
2.4.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 GlaxoSmithKline Recent Developments/Updates
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Prescription Gastrointestinal Drugs Product and Services
2.5.4 Merck Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merck Recent Developments/Updates
2.6 Salix Pharmaceuticals
2.6.1 Salix Pharmaceuticals Details
2.6.2 Salix Pharmaceuticals Major Business
2.6.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
2.6.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Salix Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Prescription Gastrointestinal Drugs by Manufacturer
3.1 Global Prescription Gastrointestinal Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Prescription Gastrointestinal Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Prescription Gastrointestinal Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Prescription Gastrointestinal Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Prescription Gastrointestinal Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Prescription Gastrointestinal Drugs Manufacturer Market Share in 2023
3.5 Prescription Gastrointestinal Drugs Market: Overall Company Footprint Analysis
3.5.1 Prescription Gastrointestinal Drugs Market: Region Footprint
3.5.2 Prescription Gastrointestinal Drugs Market: Company Product Type Footprint
3.5.3 Prescription Gastrointestinal Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Prescription Gastrointestinal Drugs Market Size by Region
4.1.1 Global Prescription Gastrointestinal Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Prescription Gastrointestinal Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Prescription Gastrointestinal Drugs Average Price by Region (2019-2030)
4.2 North America Prescription Gastrointestinal Drugs Consumption Value (2019-2030)
4.3 Europe Prescription Gastrointestinal Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value (2019-2030)
4.5 South America Prescription Gastrointestinal Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Prescription Gastrointestinal Drugs Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
5.2 Global Prescription Gastrointestinal Drugs Consumption Value by Type (2019-2030)
5.3 Global Prescription Gastrointestinal Drugs Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
6.2 Global Prescription Gastrointestinal Drugs Consumption Value by Application (2019-2030)
6.3 Global Prescription Gastrointestinal Drugs Average Price by Application (2019-2030)
7 North America
7.1 North America Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
7.2 North America Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
7.3 North America Prescription Gastrointestinal Drugs Market Size by Country
7.3.1 North America Prescription Gastrointestinal Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Prescription Gastrointestinal Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Prescription Gastrointestinal Drugs Market Size by Country
8.3.1 Europe Prescription Gastrointestinal Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Prescription Gastrointestinal Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Prescription Gastrointestinal Drugs Market Size by Region
9.3.1 Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
10.2 South America Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
10.3 South America Prescription Gastrointestinal Drugs Market Size by Country
10.3.1 South America Prescription Gastrointestinal Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Prescription Gastrointestinal Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Prescription Gastrointestinal Drugs Market Size by Country
11.3.1 Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Prescription Gastrointestinal Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Prescription Gastrointestinal Drugs Market Drivers
12.2 Prescription Gastrointestinal Drugs Market Restraints
12.3 Prescription Gastrointestinal Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Prescription Gastrointestinal Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prescription Gastrointestinal Drugs
13.3 Prescription Gastrointestinal Drugs Production Process
13.4 Prescription Gastrointestinal Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prescription Gastrointestinal Drugs Typical Distributors
14.3 Prescription Gastrointestinal Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Prescription Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Prescription Gastrointestinal Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Prescription Gastrointestinal Drugs Product and Services
Table 6. AstraZeneca Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Axcan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Axcan Pharmaceuticals Major Business
Table 10. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
Table 11. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Axcan Pharmaceuticals Recent Developments/Updates
Table 13. Eisai Basic Information, Manufacturing Base and Competitors
Table 14. Eisai Major Business
Table 15. Eisai Prescription Gastrointestinal Drugs Product and Services
Table 16. Eisai Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Eisai Recent Developments/Updates
Table 18. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Prescription Gastrointestinal Drugs Product and Services
Table 21. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. GlaxoSmithKline Recent Developments/Updates
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Prescription Gastrointestinal Drugs Product and Services
Table 26. Merck Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Merck Recent Developments/Updates
Table 28. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Salix Pharmaceuticals Major Business
Table 30. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product and Services
Table 31. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Salix Pharmaceuticals Recent Developments/Updates
Table 33. Global Prescription Gastrointestinal Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Prescription Gastrointestinal Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Prescription Gastrointestinal Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Prescription Gastrointestinal Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Prescription Gastrointestinal Drugs Production Site of Key Manufacturer
Table 38. Prescription Gastrointestinal Drugs Market: Company Product Type Footprint
Table 39. Prescription Gastrointestinal Drugs Market: Company Product Application Footprint
Table 40. Prescription Gastrointestinal Drugs New Market Entrants and Barriers to Market Entry
Table 41. Prescription Gastrointestinal Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Prescription Gastrointestinal Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Prescription Gastrointestinal Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Prescription Gastrointestinal Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Prescription Gastrointestinal Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Prescription Gastrointestinal Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Prescription Gastrointestinal Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Prescription Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Prescription Gastrointestinal Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Prescription Gastrointestinal Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Prescription Gastrointestinal Drugs Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Prescription Gastrointestinal Drugs Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Prescription Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Prescription Gastrointestinal Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Prescription Gastrointestinal Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Prescription Gastrointestinal Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Prescription Gastrointestinal Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Prescription Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Prescription Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Prescription Gastrointestinal Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Prescription Gastrointestinal Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Prescription Gastrointestinal Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Prescription Gastrointestinal Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Prescription Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Prescription Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Prescription Gastrointestinal Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Prescription Gastrointestinal Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Prescription Gastrointestinal Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Prescription Gastrointestinal Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Prescription Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Prescription Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Prescription Gastrointestinal Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Prescription Gastrointestinal Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Prescription Gastrointestinal Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Prescription Gastrointestinal Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Prescription Gastrointestinal Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Prescription Gastrointestinal Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Prescription Gastrointestinal Drugs Raw Material
Table 101. Key Manufacturers of Prescription Gastrointestinal Drugs Raw Materials
Table 102. Prescription Gastrointestinal Drugs Typical Distributors
Table 103. Prescription Gastrointestinal Drugs Typical Customers
List of Figures
Figure 1. Prescription Gastrointestinal Drugs Picture
Figure 2. Global Prescription Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Type in 2023
Figure 4. Oral Examples
Figure 5. Topical Examples
Figure 6. Global Prescription Gastrointestinal Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Application in 2023
Figure 8. Hospital Pharmacies Examples
Figure 9. Online Pharmacies Examples
Figure 10. Retail Pharmacies Examples
Figure 11. Global Prescription Gastrointestinal Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Prescription Gastrointestinal Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Prescription Gastrointestinal Drugs Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Prescription Gastrointestinal Drugs Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Prescription Gastrointestinal Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Prescription Gastrointestinal Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Prescription Gastrointestinal Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Prescription Gastrointestinal Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Prescription Gastrointestinal Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Prescription Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Prescription Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Prescription Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Prescription Gastrointestinal Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Prescription Gastrointestinal Drugs Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Prescription Gastrointestinal Drugs Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Prescription Gastrointestinal Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Prescription Gastrointestinal Drugs Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Prescription Gastrointestinal Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Prescription Gastrointestinal Drugs Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Prescription Gastrointestinal Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Prescription Gastrointestinal Drugs Consumption Value Market Share by Region (2019-2030)
Figure 53. China Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Prescription Gastrointestinal Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Prescription Gastrointestinal Drugs Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Prescription Gastrointestinal Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Prescription Gastrointestinal Drugs Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Prescription Gastrointestinal Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Prescription Gastrointestinal Drugs Market Drivers
Figure 74. Prescription Gastrointestinal Drugs Market Restraints
Figure 75. Prescription Gastrointestinal Drugs Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Prescription Gastrointestinal Drugs in 2023
Figure 78. Manufacturing Process Analysis of Prescription Gastrointestinal Drugs
Figure 79. Prescription Gastrointestinal Drugs Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
AstraZeneca Axcan Pharmaceuticals Eisai GlaxoSmithKline Merck Salix Pharmaceuticals
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>